Published in:
Open Access
01-12-2011 | Research article
Acupuncture for the treatment of severe acute pain in Herpes Zoster: results of a nested, open-label, randomized trial in the VZV Pain Study
Authors:
Tamara Ursini, Monica Tontodonati, Lamberto Manzoli, Ennio Polilli, Cristina Rebuzzi, Gabriele Congedo, Sonia Di Profio, Patrizia Marani Toro, Augusta Consorte, Giuseppina Placido, Stefano Laganà, Claudio D'Amario, Carla Granchelli, Giustino Parruti, Lucio Pippa, the VZV Pain Study Group
Published in:
BMC Complementary Medicine and Therapies
|
Issue 1/2011
Login to get access
Abstract
Background
Data on the potential efficacy of acupuncture (AC) in controlling intense or very intense pain in patients with Herpes Zoster (HZ) has not been so far adequately assessed in comparison with standard pharmacological treatment (ST) by a controlled trial design.
Methods
Within the VZV Pescara study, pain was assessed in HZ patients on a Visual Analogue Scale (VAS) and by the McGill Pain Questionnaire (MPQ) both at the beginning and at the end of treatment. Response rates, mean changes in pain intensity, differences in total pain burden with an area-under-the-curve (AUC) method over a 1-year follow-up and differences in the incidence of Post-Herpetic Neuralgia (PHN) were evaluated.
Results
One hundred and two patients were randomized to receive either AC (n = 52) or ST (n = 50) for 4 weeks. Groups were comparable regarding age, sex, pain intensity at presentation and missed antiviral prescription. Both interventions were largely effective. No significant differences were observed in response rates (81.6% vs 89.2%, p = 0.8), mean reduction of VAS (4.1 +/- 2.3 vs 4.9 +/- 1.9, p = 0.12) and MPQ scores (1.3 +/- 0.9 vs 1.3 +/- 0.9, p = 0.9), incidence of PHN after 3 months (48.4% vs 46.8%, p = 0.5), and mean AUC during follow-up (199 +/- 136 vs 173 +/- 141, p = 0.4). No serious treatment-related adverse event was observed in both groups.
Conclusions
This controlled and randomized trial provides the first evidence of a potential role of AC for the treatment of acute herpetic pain.
Trial registration
ChiCTR-TRC-10001146.